Traws Pharma, Inc. (TRAW)
(Delayed Data from NSDQ)
$1.86 USD
-0.02 (-1.06%)
Updated Sep 24, 2025 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TRAW 1.86 -0.02(-1.06%)
Will TRAW be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TRAW based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TRAW
TRAW forms Calm After Storm on September 23
The technical outlook for TRAW is unchanged after it falls 5.91% on September 22
Is TRAW compressing before expansion? Calm After Storm shows up after slipping 1.46%
Calm After Storm appears for TRAW after 3.52% move
TRAW forms Boomer Buy Setup on September 17